<![CDATA[Biogen Idec 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=20987>Thu, 14 May 2026 05:58:49 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Biogen Idec Presents Positive Interim Results from Phase 1B Study of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) at 2015 AD/PD™ Conference]]>https://www.newswire.co.kr/newsRead.php?no=786581Mon, 23 Mar 2015 11:20:00 +0900<![CDATA[PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis]]>https://www.newswire.co.kr/newsRead.php?no=759785Thu, 24 Jul 2014 10:20:00 +0900<![CDATA[TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis]]>https://www.newswire.co.kr/newsRead.php?no=735633Wed, 05 Feb 2014 14:10:00 +0900<![CDATA[CHMP Determines Dimethyl Fumarate in TECFIDERA® to be a New Active Substance in the European Union]]>https://www.newswire.co.kr/newsRead.php?no=724820Mon, 25 Nov 2013 11:08:37 +0900